Cargando…
Chaihuang-Yishen Granule Inhibits Diabetic Kidney Disease in Rats through Blocking TGF-β/Smad3 Signaling
OBJECTIVE: Increasing evidence shows that TGF-β1 is a key mediator in diabetic nephropathy (DN) and induces renal fibrosis positively by Smad3 but negatively by Smad7. However, treatment of DN by blocking the TGF-β/Smad pathway remains limited. The present study investigated the anti-fibrotic effect...
Autores principales: | Zhao, Ting Ting, Zhang, Hao Jun, Lu, Xiao Guang, Huang, Xiao Ru, Zhang, Wei Ku, Wang, Hua, Lan, Hui Yao, Li, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960111/ https://www.ncbi.nlm.nih.gov/pubmed/24646636 http://dx.doi.org/10.1371/journal.pone.0090807 |
Ejemplares similares
-
Asiatic Acid Inhibits Liver Fibrosis by Blocking TGF-beta/Smad Signaling In Vivo and In Vitro
por: Tang, Li-xia, et al.
Publicado: (2012) -
Yishen Qingli Heluo Granule in the Treatment of Chronic Kidney Disease: Network Pharmacology Analysis and Experimental Validation
por: Sun, Xian, et al.
Publicado: (2022) -
TGF-β/Smad signaling in renal fibrosis
por: Meng, Xiao-Ming, et al.
Publicado: (2015) -
Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin
por: Meng, Xiao-ming, et al.
Publicado: (2015) -
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway
por: Wang, Dongdong, et al.
Publicado: (2018)